The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: . 2011;(2): 17‑23

Read: 1416 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. . 2011;(2):17‑23. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Qureshi A.I., Ezzeddine M.A., Nasar A., et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007;25:32—38.
  2. Leonardi-Bee J., Bath P.M., Phillips S.J., Sandercock P.A. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315—1320.
  3. Willmot M., Leonardi-Bee J., Bath P.M. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004;43:18—24.
  4. Qureshi A.I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008;118:176—187.
  5. Geeganage C., Bath P.M. Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2010;7:CD002839.
  6. Adams H.P. Jr, del Zoppo G., Alberts M.J., et al. Guidelines for the early mnagement of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affi rms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478—534.
  7. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457—507.
  8. Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007;116:e391—413.
  9. Strandgaard S. Autoregulation of cerebral circulation in hypertension. Acta Neurol Scand 1978;57 (suppl 66):1—82.
  10. Wahlgren N.G., MacMahon D.G., De Keyser J., et al. Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke. Cerebrovasc Dis 1994;4:204—210.
  11. Fagan S.C., Kozak A., Hill W.D., et al. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens 2006;24:535—539.
  12. Kozak W., Kozak A., Johnson M.H., et al. Vascular protection with candesartan after experimental acute stroke in hypertensive rats:a dose-response study. J Pharmacol Exp Ther 2008;326:773—782.
  13. Schrader J., Luders S., Kulschewski A., et al. The ACCESS Study:evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003;34:1699—1703.
  14. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al., for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995—1003.
  15. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145—153.
  16. Lithell H., Hansson L., Skoog I., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875—886.
  17. Oliveira-Filho J., Silva S.C., Trabuco C.C., et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003;61:1047—1051.
  18. Geeganage C., Tracy M., England T., for TAIST Investigators. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2011;42:491—493.
  19. Morgenstern L.B., Hemphill J.C. III, Anderson C., on behalf of the American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral haemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108—2129.
  20. Aries M.J., Elting J.W., De Keyser J., et al. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 2010;41:2697—2704.
  21. Geeganage C., Bath P.M.W. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2008;4:CD000039.
  22. Geeganage C, Bath P.M.W. Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2010;7:CD002839.
  23. Potter J.F., Robinson T.G., Ford G.A., et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009;8:48—56.
  24. Schrader J., Lüders S., Kulschewski A., et al., on behalf of the ACCESS Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34:1699—1703.
  25. Anderson C.S., Huang Y., Wang J,G., et  al., for the INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008;7:391—399.
  26. Delcourt C., Huang Y., Wang J., for the INTERACT2 Investigators. The second (main) phase of an open, randomised, multicentre study to investigate the eff ectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010;5:110—116.
  27. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Int J Stroke 2006;1:245—249.
  28. Robinson T.G., Potter J.F., Ford G.A., et al., on behalf of the COSSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010;9:767—775.
  29. Hankey G.J. Lowering blood pressure in acute stroke: the SCAST trial. Lancet 2011;377:696—698.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.